{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:17:45Z","timestamp":1769149065938,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Systemc sclerosis (SSc) is an autoimmune disorder characterized by fibrosis of the skin and internal organs. Recently, it has been shown that leucine-rich \u03b1-2 glycoprotein (LRG) functions as a modulator of transforming growth factor-\u03b2 (TGF-\u03b2) signaling in fibrosis. We aimed to characterize the effect of LRG in SSc model and SSc patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Histological analysis was performed on LRG knockout (KO) and wild type (WT) mouse in the skin and the lung after bleomycin administration. Serum LRG levels were measured during the injection period. Gene expression analysis of the skin and lung tissue from LRG KO and WT mice was performed. In addition, serum LRG levels were determined in SSc patients and healthy controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>LRG KO mice display an inhibition of fibrosis in the skin in association with a decrease of dermal thickness, collagen deposition, and phospho-Smad3 expression after bleomycin. Serum LRG concentration significantly increased in WT mice after bleomycin. There was also a suppression of inflammation and fibrosis in the LRG KO mouse lung indicated by a reduction of lung weight, collagen content, and phospho-Smad3 expression after bleomycin. Gene expressions of TGF-\u03b2 and Smad2\/3 were significantly reduced in LRG KO mice. Serum LRG levels in SSc patients were significantly higher than those in controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>LRG promotes fibrotic processes in SSc model through TGF-\u03b2-Smad3 signaling, and LRG can be a biomarker for SSc in humans and also a potential therapeutic target for SSc.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1080\/14397595.2021.1883841","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T22:55:04Z","timestamp":1612479304000},"page":"1120-1128","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["The involvement of leucine-rich \u03b1-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model"],"prefix":"10.1093","volume":"31","author":[{"given":"Hideki","family":"Nakajima","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Serada","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Naka","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetoshi","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"issue":"10103","key":"2021101808424483300_CIT0001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"2021101808424483300_CIT0002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"issue":"8","key":"2021101808424483300_CIT0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2006.06.001","article-title":"Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis","volume":"5","author":"Verrecchia","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2021101808424483300_CIT0004","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3390\/ijms21093069","article-title":"Pathogenic roles of autoantibodies and aberrant epigenetic regulation of immune and connective tissue cells in the tissue fibrosis of patients with systemic sclerosis","volume":"21","author":"Tsai","year":"2020","journal-title":"IJMS"},{"issue":"4","key":"2021101808424483300_CIT0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.118919","article-title":"iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases","volume":"69","author":"Serada","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2021101808424483300_CIT0006","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jdermsci.2017.01.008","article-title":"Leucine-rich \u03b1-2 glycoprotein is an innovative biomarker for psoriasis","volume":"86","author":"Nakajima","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"7","key":"2021101808424483300_CIT0007","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.82.7.1906","article-title":"Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum","volume":"82","author":"Takahashi","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7458","key":"2021101808424483300_CIT0008","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"issue":"13","key":"2021101808424483300_CIT0009","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.18632\/oncotarget.3557","article-title":"Leucine-rich \u03b1-2-glycoprotein promotes TGF\u03b21-mediated growth suppression in the Lewis lung carcinoma cell lines","volume":"6","author":"Takemoto","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2021101808424483300_CIT0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-017-1349-2","article-title":"Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-\u03b2-Smad2 signaling in na\u00efve helper T cells","volume":"19","author":"Urushima","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"24","key":"2021101808424483300_CIT0011","doi-asserted-by":"crossref","first-page":"e13556","DOI":"10.14814\/phy2.13556","article-title":"Leucine-rich \u03b1-2 glycoprotein promotes lung fibrosis by modulating TGF-\u03b2 signaling in fibroblasts","volume":"5","author":"Honda","year":"2017","journal-title":"Physiol Rep"},{"issue":"1","key":"2021101808424483300_CIT0012","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","article-title":"Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis","volume":"67","author":"Takahashi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"2021101808424483300_CIT0013","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1183\/09031936.02.00272902","article-title":"Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice","volume":"20","author":"Lok","year":"2002","journal-title":"Eur Respir J"},{"issue":"11","key":"2021101808424483300_CIT0014","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2021101808424483300_CIT0015","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.1000148","article-title":"Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model","volume":"186","author":"Nakajima","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"2021101808424483300_CIT0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/jid.2014.426","article-title":"Psoriatic inflammation facilitates the onset of arthritis in a mouse model","volume":"135","author":"Yamamoto","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2021101808424483300_CIT0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1524-475X.1995.30108.x","article-title":"Wound healing in the transforming growth factor-\u03b21-deficient mouse","volume":"3","author":"Brown","year":"1995","journal-title":"Wound Repair Regen"},{"issue":"2","key":"2021101808424483300_CIT0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/exd.13115","article-title":"IL-17A promotes neutrophilic inflammation and disturbs acute wound healing in skin","volume":"26","author":"Takagi","year":"2017","journal-title":"Exp Dermatol"},{"issue":"4","key":"2021101808424483300_CIT0019","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","article-title":"Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response","volume":"382","author":"Shirai","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2021101808424483300_CIT0020","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis","volume":"18","author":"Serada","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2021101808424483300_CIT0021","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.4049\/jimmunol.1701542","article-title":"RGC32 promotes bleomycin-induced systemic sclerosis in a murine disease model by modulating classically activated macrophage function","volume":"200","author":"Sun","year":"2018","journal-title":"J Immunol"},{"issue":"2","key":"2021101808424483300_CIT0022","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4049\/jimmunol.1002907","article-title":"Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury","volume":"186","author":"Zhou","year":"2011","journal-title":"J Immunol"},{"key":"2021101808424483300_CIT0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13046-016-0306-2","article-title":"LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1\u03b1 activation","volume":"35","author":"Zhang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"2021101808424483300_CIT0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) )","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir Res"},{"issue":"4","key":"2021101808424483300_CIT0025","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1038\/cti.2013.2","article-title":"Interleukin-6: a new therapeutic target in systemic sclerosis?","volume":"2","author":"O'Reilly","year":"2013","journal-title":"Clin Transl Immunology"},{"issue":"3-4","key":"2021101808424483300_CIT0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"Huang","year":"2015","journal-title":"Inflamm Res"},{"key":"2021101808424483300_CIT0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol Lett"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mr\/article-pdf\/31\/6\/1120\/40675968\/mr1120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mr\/article-pdf\/31\/6\/1120\/40675968\/mr1120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:56:01Z","timestamp":1642560961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/31\/6\/1120-1128\/6398446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,2]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1080\/14397595.2021.1883841","relation":{},"ISSN":["1439-7609","1439-7595"],"issn-type":[{"value":"1439-7609","type":"electronic"},{"value":"1439-7595","type":"print"}],"subject":[],"published-other":{"date-parts":[[2021,11,2]]},"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}